The Pharmacogenomics of Hydroxyurea in Sickle Cell Disease | NHLBI Trans-Omics for Precision Medicine Skip to main content

The Pharmacogenomics of Hydroxyurea in Sickle Cell Disease

Short Name
PharmHU
Institution(s)
University of Texas Health at Houston
Type of Omics
WGS
RNASeq
Approx. Sample Size 1454
Disease/Phenotype
sickle cell disease
Starting Phase
Phase 2
TOPMed Accession #
phs001466
Omics Center(s) Phase 2
Baylor College of Medicine Human Genome Sequencing Center
Omics Center(s) Phase 6
Northwest Genomics Center
Phases Involved
2
PI

Eric Boerwinkle
Co-PI
Betty Sue Pace
Vivien Sheehan
Phenotype Liaison
Carly Summarell
Data Set contact(s)
Eric Boerwinkle
Vivien Sheehan
Project
PharmHU